# BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

> **NCT00545779** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 677 (actual)

## Conditions studied

- Post-Menopausal Osteoporosis

## Interventions

- **DRUG:** Ibandronate

## Key facts

- **NCT ID:** NCT00545779
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 677 (ACTUAL)
- **Last updated:** 2016-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545779, "BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00545779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*